TFG-MET fusion in an infantile spindle cell sarcoma with neural features

Keyphrases

• Gene Fusion 100%
• Neural Features 100%
• MET Fusion 100%
• Spindle Cell Sarcoma 100%
• Infantile Fibrosarcoma 66%
• MET Gene 66%
• Tumor 33%
• Clinical Trials 33%
• Tumor Subtype 33%
• Targeted Therapy 33%
• H3K27me3 33%
• Immunoreactivity 33%
• Fascicular 33%
• Malignant Peripheral Nerve Sheath Tumor (MPNST) 33%
• Chromosomal Translocation 33%
• Cell Phenotype 33%
• Sarcoma 33%
• Spindle Cell 33%
• Soft Tissue Mass 33%
• Pathologic 33%
• Neuroectodermal Differentiation 33%
• Immunoprofiling 33%
• S100 Proteins 33%
• Patternless 33%
• Cellular Schwannoma 33%
• SOX10 33%
• MET Inhibitor 33%
• Whole Transcriptome RNA Sequencing 33%
• Phenotypic Spectrum 33%
• Spindle Cell Rhabdomyosarcoma 33%
• Oncogenic Activation 33%

Medicine and Dentistry

• Gene Fusion 100%
• Spindle Cell Sarcoma 100%
• Neoplasm 66%
• Fibrosarcoma 66%
• Spindle Cell 66%
• Transcriptome 33%
• Clinical Trial 33%
• Carcinogenesis 33%
• RNA Sequence 33%
• Targeted Therapy 33%
• Phosphotransferase 33%
• Immunoreactivity 33%
• Chromosome Translocation 33%
• Rhabdomyosarcoma 33%
• Pelvis 33%
• S-100 Protein 33%
• Neurinoma 33%
• Connective Tissue Cancer 33%
• Genetics 33%
• Pathogenesis 33%

Biochemistry, Genetics and Molecular Biology

• Gene Fusion 100%
• Clinical Trial 33%
• Genetics 33%
• RNA Sequence 33%
• Carcinogenesis 33%
• Kinase 33%
• Phosphotransferase 33%
• Chromosomal Translocation 33%
• Staining 33%
• Immunoreactivity 33%
• SOX10 33%
• S-100 Protein 33%
• Transcriptome 33%
• Targeted Therapy 33%